Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

ClinicalTrials.gov ID: NCT06683352

Public ClinicalTrials.gov record NCT06683352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will get one shot in each arm, either a flu or COVID vaccine, alone or mixed. The study lasts about 6 months, and participants need to visit the research site at least 3 times.

Study identification

NCT ID
NCT06683352
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
BioNTech SE
Industry
Enrollment
1,353 participants

Conditions and interventions

Interventions

Biological · Combination Product · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2024 (Actual)
Primary completion
Jul 15, 2025 (Actual)
Completion
Jul 15, 2025 (Actual)
Last update posted
Aug 19, 2026

2024 – 2025

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Orange County Research Center Lake Forest California 92630 —
Artemis Institute for Clinical Research San Diego California 92103 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Clinical Research Consulting Milford Connecticut 06460 —
Indago Research & Health Center, Inc Hialeah Florida 33012 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
Palm Springs Community Health Center Miami Lakes Florida 33014 —
Headlands Research Orlando Orlando Florida 32819 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65802 —
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center Springfield Missouri 65807 —
Velocity Clinical Research, Omaha Omaha Nebraska 68134 —
Las Vegas Clinical Trials Las Vegas Nevada 89030 —
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801 —
DM Clinical Research- Cyfair Houston Texas 77065 —
SMS Clinical Research Mesquite Texas 75149 —
Dynamed Clinical Research, LP d/b/a DM Clinical Research Tomball Texas 77375 —
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109 —
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06683352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06683352 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →